Back to News
Market Impact: 0.1
Foundation Medicine’s FoundationOne®MRD Named a 2026 Top Innovation Winner by The Scientist
Source: Business Wire
Healthcare & BiotechTechnology & Innovation
Foundation Medicine's FoundationOne®MRD molecular residual disease (MRD) assay was named a 2026 Top Innovation by The Scientist. The article provides no financial figures or information about market reaction.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
More News
- AI agents could disrupt bank deposits. Why Wall Street may be overreacting
- Apple’s $2,000 iPhone Duo Debuts With Limited Supply
- OpenAI Trims Target Value & Volvo Cars Cuts 2,500 Jobs
- The real test for Moderna’s cancer vaccine isn’t about beating Keytruda. It’s keeping cancer from coming back in the long term.
- Trump Pushes DOJ Lawsuit Over Alaska Senate Race
- Oncologists Cheer Melanoma Data